OncoAlert and ecancer weekly round up for July 26 - August 1, 2021

Immunotherapy in lung cancer

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer

ASCO 2021: Lung roundup

Isatuximab, carfilzomib, lenalidomide and dexamethasone for high risk MM

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with muscle-invasive bladder cancer

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC

Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R B-cell non-Hodgkin’s lymphoma

Efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma

Breast cancer roundup from ASCO 2021

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma